重庆医科大学附属第一医院重症医学科,重庆 400016
Received:23 February 2023,
Revised:2023-03-16,
Accepted:17 April 2023,
Published:28 May 2023
移动端阅览
黄伟,林时辉,徐昉.急性呼吸窘迫综合征内表型的研究进展[J].重庆医科大学学报,2023,48(5):503-507.
Huang Wei,Lin Shihui,Xu Fang.Research progress of subphenotype of acute respiratory distress syndrome[J].Journal of Chongqing Medical University,2023,48(5):503-507.
黄伟,林时辉,徐昉.急性呼吸窘迫综合征内表型的研究进展[J].重庆医科大学学报,2023,48(5):503-507. DOI: 10.13406/j.cnki.cyxb.003221.
Huang Wei,Lin Shihui,Xu Fang.Research progress of subphenotype of acute respiratory distress syndrome[J].Journal of Chongqing Medical University,2023,48(5):503-507. DOI: 10.13406/j.cnki.cyxb.003221.
急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)是重症监护病房中一种常见的危重症疾病。由于对该疾病的认识尚且不足,其诊断及治疗仍充满挑战,病死率也一直居高不下。越来越多的学者认为ARDS在临床和生物学上都具有相当大的异质性,这引起不少学者的研究兴趣。本文旨在总结ARDS内表型的研究进展,以期为更好地认识其发病机制、为患者制定个性化治疗提供参考,促进ARDS的治疗早日迈向精准医学。
Acute respiratory distress syndrome(ARDS) is a common critical disease in intensive care unit. Due to insufficient understanding of the disease,its diagnosis and treatment are still challenging,and the mortality remains high. More and more scholars believe that ARDS has considerable heterogeneity in clinical and biological aspects,which has aroused the interest of many scholars. This article aims to summarize the research progress of the subphenotype of ARDS,so as to provide reference for better understanding of its pathogenesis,formulate individual treatment for patients, and promote the treatment of ARDS towards precision medicine as soon as possible.
Definition Task Force ARDS , Ranieri VM , Rubenfeld GD , et al . Acute respiratory distress syndrome:the Berlin definition [J ] . JAMA , 2012 , 307 ( 23 ): 2526 - 2533 .
Bellani G , Laffey JG , Pham T , et al . Epidemiology,patterns of care,and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J ] . JAMA , 2016 , 315 ( 8 ): 788 - 800 .
Wang DW , Hu B , Hu C , et al . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China [J ] . JAMA , 2020 , 323 ( 11 ): 1061 - 1069 .
Yang XB , Yu Y , Xu JQ , et al . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan,China:a single-centered,retrospective,observational study [J ] . Lancet Respir Med , 2020 , 8 ( 5 ): 475 - 481 .
Levine Bernard E . Fifty years of research in ARDS. ARDS:how it all began [J ] . Am J Respir Crit Care Med , 2017 , 196 ( 10 ): 1247 - 1248 .
Bernard GR , Artigas A , Brigham KL , et al . Report of the American-European consensus conference on ARDS:definitions,mechanisms,relevant outcomes and clinical trial coordination. The Consensus Committee [J ] . Intensive Care Med , 1994 , 20 ( 3 ): 225 - 232 .
Meyer NJ , Gattinoni L , Calfee CS . Acute respiratory distress syndrome [J ] . Lancet , 2021 , 398 ( 10300 ): 622 - 637 .
Costa ELV , Slutsky AS , Brochard LJ , et al . Ventilatory variables and mechanical power in patients with acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2021 , 204 ( 3 ): 303 - 311 .
Beitler JR , Walkey AJ . The staying power of pressure- and volume-limited ventilation in acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2021 , 204 ( 3 ): 247 - 249 .
Pratik S , Meyer Nuala J , Calfee Carolyn S . Biological phenotyping in sepsis and acute respiratory distress syndrome [J ] . Annu Rev Med , 2022 , 74 : 457 - 471 .
Beitler JR , Thompson BT , Baron RM , et al . Advancing precision medicine for acute respiratory distress syndrome [J ] . Lancet Respir Med , 2022 , 10 ( 1 ): 107 - 120 .
Bos LDJ , Ware LB . Acute respiratory distress syndrome:causes,pathophysiology,and phenotypes [J ] . Lancet , 2022 , 400 ( 10358 ): 1145 - 1156 .
Hariri L , Hardin CC . Covid-19,angiogenesis,and ARDS endotypes [J ] . N Engl J Med , 2020 , 383 ( 2 ): 182 - 183 .
Li X , Ma XC . Acute respiratory failure in COVID-19:is it “typical” ARDS? [J ] . Crit Care , 2020 , 24 ( 1 ): 198 .
Gibson PG , Qin L , Puah SH . COVID-19 acute respiratory distress syndrome(ARDS):clinical features and differences from typical pre-COVID-19 ARDS [J ] . Med J Aust , 2020 , 213 ( 2 ): 54 - 56 . e1.
Ware LB , Matthay MA , Mebazaa A . Designing an ARDS trial for 2020 and beyond:focus on enrichment strategies [J ] . Intensive Care Med , 2020 , 46 ( 12 ): 2153 - 2156 .
Bos LDJ , Laffey JG , Ware LB , et al . Towards a biological definition of ARDS:are treatable traits the solution? [J ] . Intensive Care Med Exp , 2022 , 10 ( 1 ): 8 .
Reilly JP , Calfee CS , Christie JD . Acute respiratory distress syndrome phenotypes [J ] . Semin Respir Crit Care Med , 2019 , 40 ( 1 ): 19 - 30 .
Lötvall J , Akdis CA , Bacharier LB , et al . Asthma endotypes:a new approach to classification of disease entities within the asthma syndrome [J ] . J Allergy Clin Immunol , 2011 , 127 ( 2 ): 355 - 360 .
Stanski NL , Wong HR . Prognostic and predictive enrichment in sepsis [J ] . Nat Rev Nephrol , 2020 , 16 ( 1 ): 20 - 31 .
Papazian L , Forel JM , Gacouin A , et al . Neuromuscular blockers in early acute respiratory distress syndrome [J ] . N Engl J Med , 2010 , 363 ( 12 ): 1107 - 1116 .
Claude G , Jean R , Jean-Christophe R , et al . Prone positioning in severe acute respiratory distress syndrome [J ] . N Engl J Med , 2013 , 368 : 2159 - 2168 .
Yoshida T , Kavanagh BP , Brochard L . Early neuromuscular blockade in the acute respiratory distress syndrome [J ] . N Engl J Med , 2019 , 381 ( 8 ): 786 - 787 .
Maiolo G , Collino F , Vasques F , et al . Reclassifying acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2018 , 197 ( 12 ): 1586 - 1595 .
Wilson JG , Calfee CS . ARDS subphenotypes:understanding a heterogeneous syndrome [J ] . Critical Care(London,England) , 2020 , 24 ( 1 ): 102 .
Gattinoni L , Coppola S , Cressoni M , et al . COVID-19 does not lead to a “typical” acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2020 , 201 ( 10 ): 1299 - 1300 .
Gattinoni L , Chiumello D , Caironi P , et al . COVID-19 pneumonia:different respiratory treatments for different phenotypes? [J ] . Intensive Care Med , 2020 , 46 ( 6 ): 1099 - 1102 .
Graf J , Pérez R , López R . Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS [J ] . J Crit Care , 2022 , 71 : 154095 .
Monteiro ACC , Vangala S , Wick KD , et al . The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial [J ] . Crit Care , 2022 , 26 ( 1 ): 297 .
Shaver CM , Bastarache JA . Clinical and biological heterogeneity in acute respiratory distress syndrome:direct versus indirect lung injury [J ] . Clin Chest Med , 2014 , 35 ( 4 ): 639 - 653 .
Calfee CS , Janz DR , Bernard GR , et al . Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies [J ] . Chest , 2015 , 147 ( 6 ): 1539 - 1548 .
Thille AW , Richard JC , Maggiore SM , et al . Alveolar recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome:comparison using pressure-volume curve or static compliance [J ] . Anesthesiology , 2007 , 106 ( 2 ): 212 - 217 .
Reilly JP , Bellamy S , Shashaty MG , et al . Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma [J ] . Ann Am Thorac Soc , 2014 , 11 ( 5 ): 728 - 736 .
Zhang RY , Wang ZX , Tejera P , et al . Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality:a two-stage association study [J ] . Intensive Care Med , 2017 , 43 ( 3 ): 399 - 407 .
Liao KM , Chen CW , Hsiue TR , et al . Timing of acute respiratory distress syndrome onset is related to patient outcome [J ] . J Formos Med Assoc , 2009 , 108 ( 9 ): 694 - 703 .
Warren MA , Zhao Z , Koyama T , et al . Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS [J ] . Thorax , 2018 , 73 ( 9 ): 840 - 846 .
Jabaudon M , Audard J , Pereira B , et al . Early changes over time in the radiographic assessment of lung edema score are associated with survival in ARDS [J ] . Chest , 2020 , 158 ( 6 ): 2394 - 2403 .
Matthay MA , Arabi YM , Siegel ER , et al . Phenotypes and personalized medicine in the acute respiratory distress syndrome [J ] . Intensive Care Med , 2020 , 46 ( 12 ): 2136 - 2152 .
Mrozek S , Jabaudon M , Jaber S , et al . Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS:a prospective multicenter study [J ] . Chest , 2016 , 150 ( 5 ): 998 - 1007 .
Constantin JM , Jabaudon M , Lefrant JY , et al . Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France(the LIVE study):a multicentre,single-blind,randomised controlled trial [J ] . Lancet Respir Med , 2019 , 7 ( 10 ): 870 - 880 .
Mori M , Krumholz HM , Allore HG . Using latent class analysis to identify hidden clinical phenotypes [J ] . JAMA , 2020 , 324 ( 7 ): 700 - 701 .
Calfee CS , Delucchi K , Parsons PE , et al . Subphenotypes in acute respiratory distress syndrome:latent class analysis of data from two randomised controlled trials [J ] . Lancet Respir Med , 2014 , 2 ( 8 ): 611 - 620 .
Delucchi K , Famous KR , Ware LB , et al . Stability of ARDS subphenotypes over time in two randomised controlled trials [J ] . Thorax , 2018 , 73 ( 5 ): 439 - 445 .
Famous KR , Delucchi K , Ware LB , et al . Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy [J ] . Am J Respir Crit Care Med , 2017 , 195 ( 3 ): 331 - 338 .
Calfee CS , Delucchi KL , Sinha P , et al . Acute respiratory distress syndrome subphenotypes and differential response to simvastatin:secondary analysis of a randomised controlled trial [J ] . Lancet Respir Med , 2018 , 6 ( 9 ): 691 - 698 .
Sinha P , Delucchi KL , Thompson BT , et al . Latent class analysis of ARDS subphenotypes:a secondary analysis of the statins for acutely injured lungs from sepsis(SAILS)study [J ] . Intensive Care Med , 2018 , 44 ( 11 ): 1859 - 1869 .
Sinha P , Delucchi KL , McAuley DF , et al . Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes:a secondary analysis of randomised controlled trials [J ] . Lancet Respir Med , 2020 , 8 ( 3 ): 247 - 257 .
Sinha P , Churpek MM , Calfee CS . Machine learning classifier models can identify acute respiratory distress syndrome phenotypes using readily available clinical data [J ] . Am J Respir Crit Care Med , 2020 , 202 ( 7 ): 996 - 1004 .
Maddali MV , Churpek M , Pham T , et al . Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data:an observational,multicohort,retrospective analysis [J ] . Lancet Respir Med , 2022 , 10 ( 4 ): 367 - 377 .
Bos LD , Schouten LR , van Vught LA , et al . Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis [J ] . Thorax , 2017 , 72 ( 10 ): 876 - 883 .
Bos LDJ , Scicluna BP , Ong DSY , et al . Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles [J ] . Am J Respir Crit Care Med , 2019 , 200 ( 1 ): 42 - 50 .
0
Views
7
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
